The "RNA world" hypothesis proposes that the earliest life on Earth may have been based on RNA—a single-stranded molecule ...

Texas A&M AgriLife researchers uncovered a promising target for controlling gene expression and other cellular processes, ...

Discover methods for accurate DNA and RNA quantification and learn how to analyze purity and concentration to enhance ...

Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein ...

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision ...

B.Riley Financial analyst Madison Elsaadi has reiterated their bullish stance on WVE stock, giving a Buy rating on October 31. Madison Elsaadi ...

In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

Cancer, a disease with global impact, is intricately linked to dysregulated gene expression, which is influenced by both ...

A study from Kumamoto University reveals that G-quadruplex RNA structures facilitate the aggregation of α-synuclein, a ...

Oxford Nanopore Technologies observes that direct analysis has already enhanced research across species, disease states, and applications.

HG202 is the first-ever clinical-stage CRISPR/Cas13 RNA-editing and the only clinical-stage RNA-targeting therapy for nAMD. “This open IND for HG202 by the US FDA – the first regulator to have cleared ...

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company, announced that the U.S. FDA has cleared its investigational new drug (IND) application for HG202, the world's first ...